Kura Oncology Announces Publication of Tipifarnib Phase 2 Data in Journal of Clinical Oncology

NEXT STORY
Blood Sugar Blaster Reviews – Diabetes Supplement launched
PREV STORY
Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals Congratulates Scientific Advisory Board Member Gregg L. Semenza For Receiving 2019 Nobel Prize in Medicine

author_avatar
NASDAQ Market News

Triphase Accelerator Corporation Announces Positive Preclinical Results for CBZed-Nano™ in Docetaxel-Resistant Prostate Cancer Models

TORONTO and SAN DIEGO, April 18, 2016 (GLOBE NEWSWIRE) -- Triphase Accelerator Corporation, a ...

author_avatar
NASDAQ Market News